Investor Relations



Evonik has published its quarterly report Q3 2022 on November 8, 2022.

You can access further information here.

  • Solid results in an increasingly challenging market environment: Adj. EBITDA of €615 m in Q3 – supported by a strong Specialty Additives performance (+8% yoy)
  • Volumes decline, pricing holding up: Double-digit price increases across all growth divisions resulting in ongoing successful pass-on of higher variable costs
  • Cash generation picking up with FCF of €288 m in Q3; further significant NWC improvement expected in Q4 to achieve ~30% cash conversion for the full year
  • Outlook for FY 2022 confirmed: Adj. EBITDA between €2.5 and 2.6 bn

Reporting 3rd  Quarter 2022

Link / PDF
Analyst & Investor Factsheet
Presentation Conference Call

Detailed overview of key financial data (Evonik Financials) - as PDF

Detailed overview of key financial data (Evonik Financials) - as Excel

Quarterly Statement Q3 2022

Investor Relations News Q3 2022

Analysts' consensus* (Vara Research)

Webcast Conference Call Q3-Reporting
(November 8,  2022 11.00 a.m. CET)

* The consensus is not controlled, changed or censored by Evonik Industries AG. Evonik Industries AG assumes no liability for the accuracy and completeness of these estimates and undertakes no obligation to update or revise such estimates and consensus data, even if they differ from Evonik Industries AG’s own forecasts or expectations. Evonik Industries AG is neither involved in the collection of the data, nor in the preparation of the consensus. This is done independently by Vara Research.